{"id":"W1902231903","doi":"10.1089/jamp.2013.1037","title":"Acute Hyperkalemia Associated with Inhalation of a Potent ENaC Antagonist: Phase 1 Trial of GS-9411","year":2013,"lang":"en","type":"article","venue":"Journal of Aerosol Medicine and Pulmonary Drug Delivery","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"ca_institutions":"Gilead Sciences (Canada)","funders":"Gilead Sciences","keywords":"Hyperkalemia; Medicine; Placebo; Urine sodium; Tolerability; Urine; Internal medicine; Anesthesia; Adverse effect; Endocrinology; Gastroenterology; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001277229,0.001356913,0.001658333,0.0002633558,0.000378445,0.0007207378,0.0008447989,0.001210805,0.003630924],"category_scores_gemma":[0.0009026242,0.0005559066,0.0009663887,0.0002414728,0.0008112708,0.0006862535,0.0002606152,0.002570113,0.0006012357],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006151851,"about_ca_system_score_gemma":0.001073561,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005511976,"about_ca_topic_score_gemma":0.001434244,"domain_scores_codex":[0.9996407,0.0001757907,0.00001919246,0.00006880021,0.00003392029,0.00006151615],"domain_scores_gemma":[0.9994715,0.0001045706,0.0001651377,0.00003996698,0.00004261536,0.0001762089],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8950684,0.03260344,0.003325528,0.000829799,0.001048275,0.0001726398,0.0001428142,0.0009131089,0.03082822,0.0001317324,0.001867249,0.03306893],"study_design_scores_gemma":[0.7061197,0.2830883,0.006575214,0.00002999923,0.0004554668,0.0001769822,0.00004037393,0.0005849208,0.002186961,0.00009613129,0.0006260352,0.00001997385],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961147,0.001230387,0.0003104002,0.0003237102,0.0000844758,0.0009532293,0.000368673,0.00007842325,0.0005359806],"genre_scores_gemma":[0.9938899,0.001201426,0.0009211867,0.0006275666,0.0001887838,0.001263997,0.0006387206,0.00001798308,0.001250469],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003630924,"threshold_uncertainty_score":0.01214671,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01744542694325159,"score_gpt":0.2947888883588506,"score_spread":0.2773434614155991,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}